Overview

This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developments in the field of chronic hepatitis and its various entities. In recent decades we have learned how heterogeneous the clinical entity of chronic hepatitis has become. The liver, as the central organ of metabolism and detoxification, is more than ever a target of disease processes evolving from the spread of obesity in the western world. Apart from nonalcoholic steatohepatitis (NASH), alcoholic liver disease is still the most prevalent liver disease in the west. Alcohol-induced liver disease exhibits a broad clinical spectrum from alcoholic steatohepatitis to cirrhosis. Alcoholic hepatitis is a disease entity with a particular poor prognosis. Any liver disease of unknown cause is suspected as being drug-associated. Every new drug metabolized in the liver has the potential to damage the liver. Primary biliary cirrhosis has seen significant progress due to the identification of new risk factors based on new epidemiological studies. Interface hepatitis has become a prognostic marker as well as a therapeutic target. The treatment of autoimmune hepatitis has progressed significantly due to an individualized approach to immunosuppression.

Full Product Details

Author:   A. M. Diehl ,  N. Hayashi ,  M. P. Manns ,  T. Sauerbruch
Publisher:   Springer-Verlag New York Inc.
Imprint:   Springer-Verlag New York Inc.
Edition:   2007 ed.
Volume:   157
Dimensions:   Width: 15.50cm , Height: 2.30cm , Length: 23.50cm
Weight:   0.582kg
ISBN:  

9781402065224

ISBN 10:   1402065221
Pages:   258
Publication Date:   21 August 2007
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock  
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Contents List of principal contributors List of chairpersons Preface SECTION I: METABOLIC AND TOXIC HEPATITIS.- 1 NASH: bench to bedside -- lessons from animal models.- 2 Alcohol-induced hepatitis: pathophysiology and treatment.- 3 Drug-induced hepatitis.- SECTION II: CHOLESTATIC HEPATITIS 4 Liver disease in pregnancy: diagnosis and treatment.- 5 Geoepidemiology of primary biliary cirrhosis.-6 Interface hepatitis in primary biliary cirrhosis: prognostic marker and therapeutic target.- SECTION III: VIRAL HEPATITIS (PART 1).- 7 Pathobiology of hepatitis B virus infection.- 8 Individualized treatment of hepatitis C.- SECTION IV: VIRAL HEPATITIS (PART 2).- 9 The future in the treatment of hepatitis C.- 10 Treatment of interferon non-responder patients with chronic hepatitis C in Asia.- SECTION V: AUTOIMMUNE HEPATITIS.- 11 Update on autoimmune hepatitis.- 12 Overlap syndromes Laudatio on the occasion of Professor Gerok's 80th birthday.- 13 Wolfgang Gerok State-of-the-Art Lecture: Pathogenesis of hepatic encephalopathy.- SECTION VI: SEQUELAE OF CHRONIC HEPATITIS (PART 1) Presentation of the International Dame Sheila Sherlock Award.- 14 Award Lecture: Past, present and future of hepatology.- 15 Progression of chronic hepatitis: from inflammation to fibrosis.- 16 Treatment of portal hypertension and variceal bleeding.- 17 Management of ascites and spontaneous bacterial peritonitis.- SECTION VII: SEQUELAE OF CHRONIC HEPATITIS (PART 2).- 18 Advances in the pathogenesis and treatment of type 1 and type 2 hepatorenal syndrome.- 19 Hepatopulmonary syndrome.- 20 Hepatocellular carcinoma Index

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions